What Embion Technologies does

Embion Technologies SA is a Swiss biotech company headquartered in Etoy, Switzerland, founded in 2016 as a spin-off from EPFL (École Polytechnique Fédérale de Lausanne). The company develops a patented hydrolysis platform that breaks down the cell wall structure of second-generation biomass — specifically brewers' spent grains — to release bioactive molecules, which it positions as a circular-economy input for functional nutrition and sustainability applications.

The company's first and currently sole commercial product is PREMBION®, a microbiome modulator composition (MMC) targeted at the animal protein industry as a natural alternative to antibiotics in livestock farming. PREMBION is described as 100% made from brewers' spent grains, thermostable up to 100°C, non-GMO, and designed to modulate gut microbiota in animals including broiler chickens (the primary entry species), with stated expansion intent into ruminants and other species. Embion generates revenue through direct B2B sales of PREMBION to feed manufacturers and livestock producers across a regional European footprint, supplemented by a stated but undisclosed technology-licensing stream. The company's go-to-market is sales-led and consultative, explicitly courting "first movers and innovators" as partners and inviting direct contact for territory-specific inquiries.

Embion is privately held and venture-backed, having raised approximately CHF 4.5 million in a Series A round in December 2021 led by Asahi Group Holdings Ltd. with participation from undisclosed private investors, in addition to earlier pre-seed and seed financing from sources including Venture Kick and the Foundation for Innovation and Technology (FIT). Co-founders Georgios Savoglidis (CEO and Chairman), Sviatlana Siankevich (CTO) and Georgios Fengos (COO) lead the company, with Eric Nicolas serving on the board. Embion's stated sustainability targets include upcycling 1 million tons of biomass and reducing 100 million tons of CO2 emissions by 2025, addressing a globally available 40 million tons per year of brewers' spent grain waste.

Name

Embion Technologies

Legal name

Embion Technologies SA

Website

https://embiontech.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Embion Technologies is a Swiss EPFL spin-off that commercializes PREMBION®, a patented microbiome modulator derived from upcycled brewers' spent grains, sold to animal protein producers as a natural antibiotic alternative in livestock feed.

Ownership category

akta.pro rank

Product category

Animal Feed Additives

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Agricultural Prod-Livestock & Animal Specialties (200), Biological Products, (No Disgnostic Substances) (2836), Food And Kindred Products (2000)

akta.pro primary industry

Probiotics, Prebiotics & Postbiotics (Direct-Fed Microbials) (AFADALAE)

akta.pro secondary industries

Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery) (HLAAAFAJ), Probiotics, Prebiotics & Synbiotics (AFADAKAC), Probiotic/Direct-Fed Microbial (DFM) Premixes (AFADAGAG)

Keywords

• Animal feed additives
• Biomass processing
• Microbiome modulators
• Biomass upcycling
• Prebiotic ingredients

Headquarters

HQ city

Lausanne

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. PREMBION Product Sales: Embion generates revenue through the sale of PREMBION, their proprietary microbiome modulator product for the animal feed industry. The product is sold to livestock farmers and feed producers as a feed additive/prebiotic ingredient.
2. Technology Licensing: The company develops biomass processing technology for functional nutrition and sustainability applications. May include licensing of their proprietary technology.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Embion Technologies manufactures and sells PREMBION, a next-generation microbiome modulator composition (MMC) feed ingredient made from upcycled brewers' spent grains using a patented hydrolysis process. The product is targeted at the animal protein industry (livestock and feed producers) as a natural prebiotic alternative to antibiotics, supporting gut health, immune function, and animal performance. The company also licenses its proprietary biomass processing technology for broader functional nutrition, cosmetic, and pharma applications.

Product overview

Embion Technologies offers a single unified product: PREMBION®, a next-generation Microbiome Modulator Composition (MMC) designed for the animal protein industry. The product is manufactured from upcycled brewers' spent grains using Embion's patented hydrolysis technology, which breaks down cell wall structures to release specific bioactive molecules that modulate the gut microbiome in animals. PREMBION serves as a natural alternative to antibiotics in animal farming, supporting animal health, immune function, and performance from the first day of life.

Differentiator

Problem solved

Functional benefit

Brands

• PREMBION: Next-generation microbiome modulator (MMC) for optimized gut health for the animal protein industry, manufactured from brewers' spent grains using a patented hydrolysis process.

Products and services

• PREMBION®

Quantifiable outcome

• 40 million tons of barley (brewers' spent grains) produced and wasted globally every year
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Qualified European Raw Material SupplierscoreOthersEmbion sources spent barley from qualified suppliers around Europe that adhere to strict standards of the feed industry.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• DSM-Firmenich: Major animal nutrition and health player with extensive feed additive portfolios including prebiotics, probiotics and performance enhancers; comparable as a broad incumbent serving the same animal feed customers with microbiome and gut-health solutions.
• Cargill Animal Nutrition: One of the largest global animal feed and nutrition companies, offering prebiotics, probiotics and gut-health solutions across species; comparable as a broad incumbent serving Embion's target customer base.
• Evonik Animal Nutrition: Large specialty chemicals company with a dedicated animal nutrition feed additives business including probiotics and essential oils; comparable as a broad incumbent in the feed additive space.
• Chr. Hansen (now Novonesis): Global leader in microbial and fermentation-based solutions including probiotics and natural feed additives for livestock; directly comparable as a large incumbent selling microbiome-modulating products into the animal protein industry.

Direct peers

• Phibro Animal Health: Animal health and nutrition company with nutritional specialty products and feed additives for livestock producers; comparable as a peer addressing gut health and antibiotic alternatives in animal protein.
• AB Vista: Animal feed additive specialist offering enzymes, prebiotics and yeast products for gut health in livestock; directly comparable as a focused feed additive peer targeting the same microbiome mechanism.
• Alltech: Animal nutrition company specializing in prebiotics, probiotics, and yeast-based feed additives; directly comparable as it markets microbiome-modulating feed ingredients to livestock producers on a global basis.
• Pancosma: Specialty feed additive company offering prebiotics, probiotics and phytogenic ingredients for animal nutrition; comparable as a focused feed additive peer in the same product category as PREMBION.
• Lallemand Animal Nutrition: Specialist in microbial-based feed additives (probiotics, yeast derivatives) for livestock and poultry; directly comparable as a focused provider of microbiome solutions to the animal protein industry.
• Kemin Industries: Ingredient manufacturer offering gut-health and immune-support feed additives for livestock and poultry; comparable as a direct competitor in functional feed ingredients targeting animal gut microbiome.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/embion-technologies
• Xx.com/Embiontech

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds8 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Embion Technologies